Clinical Trial Update: Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy of AB1010 in patients with systemic indolent mastocytosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mastocytosis

Drugs mentioned

• AB1010 (AB1010)

Snippet

Sponsor: AB Science | Conditions: Mastocytosis | Phase 2 | Status: COMPLETED